Share on StockTwits

West Pharmaceutical Services (NYSE:WST) VP John R. Gailey sold 20,000 shares of the stock on the open market in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $43.96, for a total value of $879,200.00. Following the sale, the vice president now directly owns 67,856 shares in the company, valued at approximately $2,982,950. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

West Pharmaceutical Services (NYSE:WST) traded up 0.25% during mid-day trading on Thursday, hitting $44.05. 415,934 shares of the company’s stock traded hands. West Pharmaceutical Services has a one year low of $36.77 and a one year high of $51.12. The stock’s 50-day moving average is $41.21 and its 200-day moving average is $43.32. The company has a market cap of $3.117 billion and a price-to-earnings ratio of 27.77.

West Pharmaceutical Services (NYSE:WST) last released its earnings data on Thursday, July 31st. The company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.05. The company had revenue of $368.90 million for the quarter, compared to the consensus estimate of $368.60 million. During the same quarter in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was up 7.1% on a year-over-year basis. Analysts expect that West Pharmaceutical Services will post $1.84 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, November 5th. Stockholders of record on Wednesday, October 22nd will be paid a dividend of $0.11 per share. This represents a $0.44 annualized dividend and a dividend yield of 1.00%.

Separately, analysts at Jefferies Group reiterated a “hold” rating on shares of West Pharmaceutical Services in a research note on Tuesday, August 5th. They now have a $45.00 price target on the stock, down previously from $47.00.

West Pharmaceutical Services, Inc (NYSE:WST) is a manufacturer of components and systems for the packaging and delivery of injectable drugs, as well as delivery system components for the pharmaceutical, healthcare and consumer products industries.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.